Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
207940:KRX
Samsung Biologics Co Ltd
₩1,470,000.00
-0.20%
(-3,000.00) 1D
Apr 30, 3:30:21 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 207940...
Open
₩1,474,000
High
₩1,484,000
Low
₩1,470,000
Mkt. cap
68.05T
Avg. vol.
46.91K
Volume
44.54K
P/E ratio
39.69
52-wk high
₩1,987,000
52-wk low
₩982,000
EPS
₩37,040
Shares outstanding
46.29M
No. of employees
5K
News stories
From sources across the web
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines. The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd
CEOJohn Rim
Employees4.77K
Founded2011
Headquarters-
SectorHealth care
Websitesamsungbiologics.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.29T
1.66T
1.29T
1.26T
Cost of goods sold
574.83B
685.41B
614.00B
577.00B
Cost of revenue
574.83B
685.41B
614.00B
577.00B
Research and development expenses
40.33B
34.28B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
183.27B
198.01B
144.00B
99.00B
Operating expense
239.48B
245.96B
144.00B
99.00B
Total operating expenses
814.31B
931.37B
758.00B
676.00B
Operating income
475.60B
728.85B
528.00B
581.00B
Other non operating income
2.16B
4.54B
47.00B
60.00B
EBT including unusual items
408.90B
767.00B
575.00B
641.00B
EBT excluding unusual items
408.04B
767.42B
575.00B
641.00B
Income tax expense
84.52B
192.54B
122.00B
172.00B
Effective tax rate
20.67%
25.10%
21.22%
26.83%
Other operating expenses
8.78B
597.95M
-
-
Net income
324.39B
574.46B
510.00B
469.00B
Net profit margin
25.15%
34.60%
39.66%
37.31%
Earnings per share
7.01K
8.07K
8.72K
-
Interest and investment income
12.38B
13.35B
-
-
Interest expense
-8.26B
-10.71B
-
-
Net interest expenses
4.11B
2.64B
-
-
Depreciation and amortization charges
8.40B
8.84B
-
-
EBITDA
653.80B
907.77B
-
-
Gain or loss from assets sale
-101.45M
412.61M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer